Ranitidine HCl (Form I And Form Ii) en es it fr

Ranitidine HCl (Form I And Form Ii) Brand names, Ranitidine HCl (Form I And Form Ii) Analogs

Ranitidine HCl (Form I And Form Ii) Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidine HCl (Form I And Form Ii) Chemical_Formula

C13H22N4O3S

Ranitidine HCl (Form I And Form Ii) RX_link

http://www.rxlist.com/cgi/generic2/ranitbc.htm

Ranitidine HCl (Form I And Form Ii) fda sheet

Ranitidine_HCl_(Form_I_And_Form_Ii) FDA

Ranitidine HCl (Form I And Form Ii) msds (material safety sheet)

Ranitidine_HCl_(Form_I_And_Form_Ii) MSDS

Ranitidine HCl (Form I And Form Ii) Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidine HCl (Form I And Form Ii) Molecular Weight

314.405 g/mol

Ranitidine HCl (Form I And Form Ii) Melting Point

69-70 oC

Ranitidine HCl (Form I And Form Ii) H2O Solubility

24.7 mg/mL

Ranitidine HCl (Form I And Form Ii) State

Solid

Ranitidine HCl (Form I And Form Ii) LogP

1.93

Ranitidine HCl (Form I And Form Ii) Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidine HCl (Form I And Form Ii) Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidine HCl (Form I And Form Ii) Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidine HCl (Form I And Form Ii) Absorption

Approximately 50% bioavailability orally.

Ranitidine HCl (Form I And Form Ii) side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidine HCl (Form I And Form Ii) Patient Information

PATIENT INFORMATION

Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidine HCl (Form I And Form Ii) Organisms Affected

Humans and other mammals